These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 29038205)

  • 21. SGLT-2 Inhibitors in Heart Failure and Type-2 Diabetes: Hitting Two Birds with One Stone?
    Santos-Ferreira D; Gonçalves-Teixeira P; Fontes-Carvalho R
    Cardiology; 2020; 145(5):311-320. PubMed ID: 31865310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
    Arnott C; Li Q; Kang A; Neuen BL; Bompoint S; Lam CSP; Rodgers A; Mahaffey KW; Cannon CP; Perkovic V; Jardine MJ; Neal B
    J Am Heart Assoc; 2020 Feb; 9(3):e014908. PubMed ID: 31992158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of Heart Failure in Patients with Diabetes: Role of Diabetes Medications.
    Bassi N; Fonarow GC
    Curr Cardiol Rep; 2018 Sep; 20(11):112. PubMed ID: 30259198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Focused Updates: SGLT2 Inhibitors in Patients With Heart Failure and/or Chronic Kidney Disease.
    Cheng JWM; Colucci V; Kalus JS; Spinler SA
    Ann Pharmacother; 2021 Feb; 55(2):252-260. PubMed ID: 32536199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sodium-glucose co-transporter 2 inhibitors for the prevention of heart failure in type 2 diabetes: A systematic review and meta-analysis.
    Yamani N; Usman MS; Akhtar T; Fatima K; Asmi N; Khan MS
    Eur J Prev Cardiol; 2020 Apr; 27(6):667-670. PubMed ID: 30966822
    [No Abstract]   [Full Text] [Related]  

  • 26. Risk stratification tools for heart failure in the diabetes clinic.
    Cannistraci R; Mazzetti S; Mortara A; Perseghin G; Ciardullo S
    Nutr Metab Cardiovasc Dis; 2020 Jun; 30(7):1070-1079. PubMed ID: 32475628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The DAPA-HF trial marks the beginning of a new era in the treatment of heart failure with reduced ejection fraction.
    Verma S
    Cardiovasc Res; 2020 Jan; 116(1):e8-e10. PubMed ID: 31850505
    [No Abstract]   [Full Text] [Related]  

  • 28. Optimising the Heart Failure Treatment Pathway: The Role of SGLT2 Inhibitors.
    Evans M; Morgan AR; Yousef Z; Ellis G; Dashora U; Patel DC; Brown P; Hanif W; Townend JN; Kanumilli N; Moore J; Wilding JPH; Bain SC
    Drugs; 2021 Jul; 81(11):1243-1255. PubMed ID: 34160822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sodium-glucose cotransporter-2 inhibitors in type 2 diabetes: a magic potion to reduce heart failure?
    Pafili K; Papanas N
    Expert Rev Clin Pharmacol; 2019 Aug; 12(8):693-695. PubMed ID: 31232616
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of heart failure with sodium glucose co-transporter-2 inhibitors in people with type 2 diabetes mellitus: current evidence and future directions.
    Sharma A; Butler J; Zieroth S; Giannetti N; Verma S
    Diabet Med; 2019 Dec; 36(12):1550-1561. PubMed ID: 31536660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Commentary: Sodium Glucose Cotransporter 2 Inhibitors Reduce the Risk of Heart Failure Hospitalization in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Qiu M; Ding LL; Zhan ZL; Zhou HR
    Front Endocrinol (Lausanne); 2021; 12():664502. PubMed ID: 33841341
    [No Abstract]   [Full Text] [Related]  

  • 32. External applicability of SGLT2 inhibitor cardiovascular outcome trials to patients with type 2 diabetes and cardiovascular disease.
    Smidt LCA; Visseren FLJ; de Ranitz-Greven WL; Nathoe HM; Kappelle LJ; de Borst GJ; de Valk HW; Westerink J;
    Cardiovasc Diabetol; 2021 Sep; 20(1):181. PubMed ID: 34496847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Empagliflozin improves cardiorespiratory fitness in type 2 diabetes: translational implications.
    Kumar N; Garg A; Bhatt DL; Sabongui S; Gupta N; Chaudhry S; Arena R; Verma S
    Can J Physiol Pharmacol; 2018 Nov; 96(11):1184-1187. PubMed ID: 30265814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium-Glucose Co-transporter 2 Inhibitors in the Failing Heart: a Growing Potential.
    Brito D; Bettencourt P; Carvalho D; Ferreira J; Fontes-Carvalho R; Franco F; Moura B; Silva-Cardoso JC; de Melo RT; Fonseca C
    Cardiovasc Drugs Ther; 2020 Jun; 34(3):419-436. PubMed ID: 32350793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventing and Treating Heart Failure with Sodium-Glucose Co-Transporter 2 Inhibitors.
    Vaduganathan M; Januzzi JL
    Am J Cardiol; 2019 Dec; 124 Suppl 1():S20-S27. PubMed ID: 31741436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association between SGLT2 inhibitors and new-onset arrhythmias: a nationwide population-based longitudinal cohort study.
    Chen HY; Huang JY; Siao WZ; Jong GP
    Cardiovasc Diabetol; 2020 Jun; 19(1):73. PubMed ID: 32503541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathways to Cardiorenal Complications in Type 2 Diabetes Mellitus: A Need to Rethink.
    Sattar N; McGuire DK
    Circulation; 2018 Jul; 138(1):7-9. PubMed ID: 29967228
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of glucose-lowering therapies on heart failure.
    Nassif M; Kosiborod M
    Nat Rev Cardiol; 2018 May; 15(5):282-291. PubMed ID: 29368701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SGLT2 inhibitors: What role do they play in heart failure with reduced ejection fraction?
    Lenahan CM; Harrington D; Stueben F
    Nurse Pract; 2021 Jul; 46(7):30-37. PubMed ID: 34138811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SGLT2 inhibitors and risk of stroke in patients with type 2 diabetes: A systematic review and meta-analysis.
    Guo M; Ding J; Li J; Wang J; Zhang T; Liu C; Huang W; Long Y; Gao C; Xu Y
    Diabetes Obes Metab; 2018 Aug; 20(8):1977-1982. PubMed ID: 29573118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.